The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion

Abstract The safety of endovascular revascularization in patients with carotid artery near occlusion (CANO) is unknown. We aimed to evaluate the peri-procedural risk in CANO patients receiving carotid artery stenting (CAS). A prospective data base with retrospective review was performed to identify...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheng-Hsuan Tsai, Ying-Hsien Chen, Mao-Shin Lin, Ching-Chang Huang, Chi-Sheng Hung, Chih-Fan Yeh, Sheng-Fu Liu, Sung-Chun Tang, Chi-Chao Chao, Hsien-Li Kao
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/90a1366eb65a473c886492e61a39f901
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:90a1366eb65a473c886492e61a39f901
record_format dspace
spelling oai:doaj.org-article:90a1366eb65a473c886492e61a39f9012021-11-14T12:18:55ZThe periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion10.1038/s41598-021-01286-32045-2322https://doaj.org/article/90a1366eb65a473c886492e61a39f9012021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01286-3https://doaj.org/toc/2045-2322Abstract The safety of endovascular revascularization in patients with carotid artery near occlusion (CANO) is unknown. We aimed to evaluate the peri-procedural risk in CANO patients receiving carotid artery stenting (CAS). A prospective data base with retrospective review was performed to identify patients who underwent CAS with CANO from July 2006 to July 2020, and had at least 1-month clinical follow-up data. The primary endpoints were stroke, hyperperfusion syndrome, and death within 30 days after CAS. A total of 198 patients with carotid artery stenosis were enrolled including 92 patients with CANO and 106 age and sex-matched patients with 70–99% conventional carotid stenosis. Full distal carotid collapse was found in 45 CANO patients (45/92, 49%). The technical success rate was 100%. The CANO patients had significantly longer lesion lengths compared with those of the non-CANO group. The incidence of hyperperfusion syndrome was comparable (CANO: 2.2%, non-CANO: 0.9%, P = 0.598). The risks of ischemic stroke and death within 30 days were 1.1% and 0% in the CANO group; and 1.9% and 0.9%, in the non-CANO group, respectively, without statistical difference. In conclusion, CAS is safe for patients with CANO, with a similar low 30-day peri-procedural event rate comparable to those of non-CANO.Cheng-Hsuan TsaiYing-Hsien ChenMao-Shin LinChing-Chang HuangChi-Sheng HungChih-Fan YehSheng-Fu LiuSung-Chun TangChi-Chao ChaoHsien-Li KaoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cheng-Hsuan Tsai
Ying-Hsien Chen
Mao-Shin Lin
Ching-Chang Huang
Chi-Sheng Hung
Chih-Fan Yeh
Sheng-Fu Liu
Sung-Chun Tang
Chi-Chao Chao
Hsien-Li Kao
The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
description Abstract The safety of endovascular revascularization in patients with carotid artery near occlusion (CANO) is unknown. We aimed to evaluate the peri-procedural risk in CANO patients receiving carotid artery stenting (CAS). A prospective data base with retrospective review was performed to identify patients who underwent CAS with CANO from July 2006 to July 2020, and had at least 1-month clinical follow-up data. The primary endpoints were stroke, hyperperfusion syndrome, and death within 30 days after CAS. A total of 198 patients with carotid artery stenosis were enrolled including 92 patients with CANO and 106 age and sex-matched patients with 70–99% conventional carotid stenosis. Full distal carotid collapse was found in 45 CANO patients (45/92, 49%). The technical success rate was 100%. The CANO patients had significantly longer lesion lengths compared with those of the non-CANO group. The incidence of hyperperfusion syndrome was comparable (CANO: 2.2%, non-CANO: 0.9%, P = 0.598). The risks of ischemic stroke and death within 30 days were 1.1% and 0% in the CANO group; and 1.9% and 0.9%, in the non-CANO group, respectively, without statistical difference. In conclusion, CAS is safe for patients with CANO, with a similar low 30-day peri-procedural event rate comparable to those of non-CANO.
format article
author Cheng-Hsuan Tsai
Ying-Hsien Chen
Mao-Shin Lin
Ching-Chang Huang
Chi-Sheng Hung
Chih-Fan Yeh
Sheng-Fu Liu
Sung-Chun Tang
Chi-Chao Chao
Hsien-Li Kao
author_facet Cheng-Hsuan Tsai
Ying-Hsien Chen
Mao-Shin Lin
Ching-Chang Huang
Chi-Sheng Hung
Chih-Fan Yeh
Sheng-Fu Liu
Sung-Chun Tang
Chi-Chao Chao
Hsien-Li Kao
author_sort Cheng-Hsuan Tsai
title The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
title_short The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
title_full The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
title_fullStr The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
title_full_unstemmed The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
title_sort periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/90a1366eb65a473c886492e61a39f901
work_keys_str_mv AT chenghsuantsai theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT yinghsienchen theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT maoshinlin theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chingchanghuang theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chishenghung theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chihfanyeh theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT shengfuliu theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT sungchuntang theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chichaochao theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT hsienlikao theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chenghsuantsai periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT yinghsienchen periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT maoshinlin periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chingchanghuang periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chishenghung periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chihfanyeh periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT shengfuliu periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT sungchuntang periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT chichaochao periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
AT hsienlikao periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion
_version_ 1718429301067481088